Jade Biosciences Balance Sheet (2020-2026) | JBIO

Balance Sheet Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Accumulated Depreciation (Quarter)
0.01M
Receivables - Accured (Quarter)
0.10M0.10M0.10M
Assets
Current Assets
Cash & Equivalents (Quarter)
59.15M180.90M54.20M28.14M27.46M22.42M22.40M26.57M60.90M32.18M23.49M9.12M31.07M88.70M69.39M76.20M220.90M50.11M88.44M55.10M
Prepaid Assets (Quarter)
0.16M2.22M0.24M4.81M1.46M2.58M0.48M1.11M2.37M2.40M0.38M1.94M6.56M1.88M0.27M0.32M2.04M2.46M12.66M7.22M
Current Assets (Quarter)
59.31M183.10M174.33M165.88M153.45M145.16M131.50M120.57M152.47M137.60M124.23M103.24M110.76M90.61M69.65M77.37M222.98M201.36M348.82M318.52M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.04M0.16M0.19M0.29M0.32M0.33M0.24M0.27M0.24M0.32M0.29M0.26M0.23M0.01M0.00M0.15M0.18M0.17M0.16M
Other Non-Current Assets (Quarter)
3.09M0.28M0.30M0.33M0.73M1.08M2.56M2.65M2.23M2.24M2.28M2.60M0.08M0.08M3.15M0.06M0.17M0.07M0.07M
Non-Current Assets (Quarter)
3.12M1.02M1.03M1.11M2.23M2.50M3.81M3.82M3.29M3.27M3.19M3.58M0.93M0.35M3.15M0.16M0.98M1.09M0.96M0.92M
Assets (Quarter)
62.43M184.12M175.36M167.00M155.68M147.66M135.30M124.39M155.75M140.88M127.42M106.82M111.69M90.96M72.80M77.53M223.97M202.45M349.78M319.43M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
3.04M2.56M1.21M2.86M2.07M4.54M2.58M4.73M5.53M3.50M2.40M3.31M4.18M0.91M1.29M0.07M7.59M1.35M2.15M3.98M
Payables (Quarter)
3.04M2.56M1.21M2.86M2.07M4.54M2.58M4.73M5.53M3.50M2.40M3.31M4.18M0.91M1.29M0.07M7.59M1.35M2.15M3.98M
Accumulated Expenses (Quarter)
1.15M1.12M0.79M1.65M1.34M1.39M2.75M5.54M1.52M10.77M14.82M9.75M2.66M4.70M4.12M1.61M8.09M14.01M9.42M14.85M
Other Accumulated Expenses (Quarter)
0.12M0.18M0.14M0.24M0.15M0.25M0.38M0.25M0.58M0.44M1.09M0.67M0.67M0.29M0.32M0.43M
Current Leases (Quarter)
0.15M0.19M0.19M0.35M0.38M0.39M0.37M0.38M0.45M0.42M0.45M0.47M0.46M0.42M0.31M
Total Current Liabilities (Quarter)
4.19M3.83M2.55M4.70M3.76M7.71M7.78M10.64M13.28M14.72M17.64M15.52M17.02M10.31M12.00M2.42M21.62M22.36M16.54M22.29M
Non-Current Liabilities
Convertible Debt (Quarter)
107.60M
Preferred Stock Liabilities (Quarter)
0.00M0.00M0.00M0.00M
Minority Interest (Quarter)
4.00M
Operating Leases (Quarter)
0.45M0.38M0.53M1.21M0.80M0.70M0.59M0.48M0.36M0.26M0.33M0.21M0.08M0.79M0.75M0.72M0.70M
Other Non-Current Liabilities (Quarter)
0.01M0.01M0.01M0.01M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M107.60M0.07M
Total Non-Current Liabilities (Quarter)
2.93M5.04M4.62M8.51M8.49M11.23M13.76M15.08M17.89M15.85M17.23M10.40M12.00M2.42M
Total Liabilities (Quarter)
84.01M4.28M2.94M5.05M4.63M8.52M8.56M11.30M13.83M15.15M17.96M15.92M17.30M10.47M119.60M2.49M22.41M23.10M17.26M22.97M
Shareholder's Equity
Common Equity (Quarter)
-21.58M179.85M172.42M161.95M151.05M139.14M126.74M113.09M141.93M125.72M109.46M90.90M-0.59M-16.86M-46.80M-83.51M201.56M179.35M332.52M296.46M
Shareholder's Equity (Quarter)
-21.58M179.85M172.42M161.95M151.05M139.14M126.74M113.09M141.93M125.72M109.46M90.90M-0.59M-16.86M-46.80M-83.51M201.56M179.35M332.52M296.46M
Liabilities and Shareholders Equity (Quarter)
62.43M184.12M175.36M167.00M155.68M147.66M135.30M124.39M155.75M140.88M127.42M106.82M111.69M90.96M72.80M77.53M223.97M202.45M349.78M319.43M
Retained Earnings (Quarter)
-21.98M-28.17M-36.39M-47.30M-59.29M-72.88M-87.90M-104.42M-0.22M-143.01M-163.42M-0.03M-211.38M-227.62M-46.98M0.05M-117.28M-142.46M0.13M-0.34M
Preferred Shares (Quarter)
0.00M0.00M0.00M0.00M
Treasury Shares (Quarter)
0.00M0.02M28.88M0.03M0.03M0.03M0.02M0.02M0.52M0.50M0.37M0.34M0.31M
Shares Outstanding (Quarter)
0.24M24.41M24.41M24.41M24.42M24.51M24.72M24.82M27.60M27.65M27.76M27.90M3.67M3.67M3.67M3.67M0.01M32.63M0.01M49.35M